176 related articles for article (PubMed ID: 35434017)
1. Siglec15 facilitates the progression of non-small cell lung cancer and is correlated with spinal metastasis.
Liang H; Chen Q; Hu Z; Zhou L; Meng Q; Zhang T; Wang B; Ge Y; Lu S; Ding W; Zhou X; Li X; Lin H; Jiang L; Dong J
Ann Transl Med; 2022 Mar; 10(6):281. PubMed ID: 35434017
[TBL] [Abstract][Full Text] [Related]
2. Siglec15 Checkpoint Blockade for Simultaneous Immunochemotherapy and Osteolysis Inhibition in Lung Adenocarcinoma Spinal Metastasis via a Hollow Nanoplatform.
Liang H; Zhou L; Hu Z; Ge Y; Zhang T; Chen Q; Wang B; Lu S; Ding W; Dong J; Xue F; Jiang L
Small; 2022 Jul; 18(29):e2107787. PubMed ID: 35751455
[TBL] [Abstract][Full Text] [Related]
3. Siglec-15 Is an Immune Suppressor and Potential Target for Immunotherapy in the Pre-Metastatic Lymph Node of Colorectal Cancer.
Du H; Tang J; Li X; Wang X; Wu L; Zhang R; Hu P; Yang Y
Front Cell Dev Biol; 2021; 9():691937. PubMed ID: 34722496
[TBL] [Abstract][Full Text] [Related]
4. Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Hu J; Yu A; Othmane B; Qiu D; Li H; Li C; Liu P; Ren W; Chen M; Gong G; Guo X; Zhang H; Chen J; Zu X
Theranostics; 2021; 11(7):3089-3108. PubMed ID: 33537076
[No Abstract] [Full Text] [Related]
5. Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas.
Wang J; Xu L; Ding Q; Li X; Wang K; Xu S; Liu B
Front Immunol; 2023; 14():1065062. PubMed ID: 37325664
[TBL] [Abstract][Full Text] [Related]
6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
7. Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma.
Xu T; Dai T; Zeng P; Song Q; He K; Hu Z; Li Y; Li Z
Transl Cancer Res; 2021 Aug; 10(8):3811-3828. PubMed ID: 35116680
[TBL] [Abstract][Full Text] [Related]
8. PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway.
Wu Q; Zhang B; Li B; Cao X; Chen X; Xue Q
Cancer Cell Int; 2020; 20():172. PubMed ID: 32477006
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
10. LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer.
Liu M; Cai R; Wang T; Yang X; Wang M; Kuang Z; Xie Y; Zhang J; Zheng Y
Ann Transl Med; 2021 Sep; 9(17):1392. PubMed ID: 34733944
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the molecular features, relevant immune and clinical characteristics of
Hou X; Chen C; Lan X; He X
Front Immunol; 2022; 13():975787. PubMed ID: 36159823
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y
J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of three Siglec15-related immune and prognostic subtypes of breast-invasive cancer.
Cao X; Zhou Y; Mao F; Lin Y; Zhou X; Sun Q
Int Immunopharmacol; 2022 May; 106():108561. PubMed ID: 35151947
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
15. Vertebral-specific activation of the CX3CL1/ICAM-1 signaling network mediates non-small-cell lung cancer spinal metastasis by engaging tumor cell-vertebral bone marrow endothelial cell interactions.
Wang K; Jiang L; Hu A; Sun C; Zhou L; Huang Y; Chen Q; Dong J; Zhou X; Zhang F
Theranostics; 2021; 11(10):4770-4789. PubMed ID: 33754027
[No Abstract] [Full Text] [Related]
16. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
18. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
19. DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.
Pan H; Chai W; Liu X; Yu T; Sun L; Yan M
Exp Cell Res; 2021 Dec; 409(1):112897. PubMed ID: 34717919
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]